Pulse - Universal CYP2C19 Genotyping in PCI

April 27, 2022

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

Target Audience

Pharmacist

Learning Objectives

Describe available P2Y12 inhibitors and CYP2C19-mediated metabolism of clopidogrel.
Define current recommendations for CYP2C19 genotype-guided antiplatelet therapy.
Discuss available literature regarding efficacy and feasibility of universal CYP2C19 genotyping.

Additional Information

AttachmentSize
PDF icon CYP2C19 Genotyping Handout.pdf113.13 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Course opens: 
04/27/2022
Course expires: 
05/27/2022
Event starts: 
04/27/2022 - 1:00pm EDT
Event ends: 
04/27/2022 - 2:00pm EDT
Add to calendar: 

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

UPMC Presbyterian
Pittsburgh, PA
United States

Taylor Werner, PharmD, 
PGY1 Pharmacy Resident
UPMC Presbyterian

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Pharmacy (CPE)

This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.

 

Available Credit

  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Please login or register to take this course.